Jeffrey Z. Mann

This profile gathers the share dealings of Jeffrey Z. Mann across 2 companies, led by Embecta Corp. and Cantel Medical Corp. Between 1 August 2019 and 12 August 2026, the trades on record add up to 22 filings.

On the market, this insider has only ever bought: 3 purchases, €225k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 18 share grants. Since January 2026: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €86k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 13 August 2026 with an open-market purchase (€86k) in Embecta Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.